Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.

Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q37951064
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases.Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.The impact of crystallization conditions on structure-based drug design: A case study on the methylene blue/acetylcholinesterase complexLigand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade.Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.Pharmacophore-based design and discovery of (-)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis.Pharmacophore generation, atom-based 3D-QSAR, HQSAR and activity cliff analyses of benzothiazine and deazaxanthine derivatives as dual A2A antagonists/MAO‑B inhibitors.Design, Synthesis and Evaluation of Hesperetin Derivatives as Potential Multifunctional Anti-Alzheimer Agents.Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy.Cholinesterases in Biorecognition and Biosensors Construction: A ReviewBenzofuran-Chalcone Hybrids as Potential Multifunctional Agents against Alzheimer’s Disease: Synthesis and in vivo Studies with TransgenicCaenorhabditis elegans
P2860

Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q37951064
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@en
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@nl
type
label
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@en
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@nl
prefLabel
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@en
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
@en
P2093
P304
P31
P356
10.2174/156802611798184409
P433
P478
P577
P698
P921